Skip Ribbon Commands
Skip to main content
Skip to main navigation Skip to main content
Sign In

The Code of Practice Appeal Board 2019

​​​​​​A complainant whose complaint has been rejected, or a company ruled in breach of the Code, may appeal the Panel's decision to the Code of Practice Appeal Board. The Panel may also report a company to the Appeal Board whose conduct in relation to the Code, in a particular case or because of repeated breaches of the Code, raises concerns about the company's procedures. In some cases a company may be required to suspend the material or activity at issue pending the outcome of an appeal.
 
The Appeal Board consists of an independent, legally qualified, chairman and eight other independent members. There are also eight senior executives from pharmaceutical companies. The Appeal Board always sits with a majority of independent members. Further details are available in the PMCPA Constitution and Procedure (see link).
 
In addition to its role in relation to appeals, the Appeal Board receives reports on all cases considered by the Panel and oversees its work.
 ​
Current members of the Code of Practice Appeal Board are: 

CHAIRMAN 

Mr William Harbage QC
 

INDEPENDENT MEMBERS

Mrs N Duke (Nurse Prescriber)

Dr H Freeman MBE (General Practitioner)

Mr C Goard (Representing patients' interests)

Mrs G Hawken (Lay)

Dr A Hawkridge (General Practitioner)

Dr J Watkins (Hospital Consultant)

Mr A White (Independent body involved in providing information on medicines)

 

INDUSTRY MEMBERS

Dr F Catterall (Head of Ethics and Compliance, Patient Value & Product Strategy (PVPS), Shire (Shire is now part of Takeda))

Dr Karen Mullen (Dr Karen Mullen, Country Medical Director UK and Ireland, GlaxoSmithKline Limited)

Dr M Toms (Chief Scientific Officer, Novartis UK)


​POSSIBLE CO-OPTEES TO THE CODE OF PRACTICE APPEAL BOARD 

Independent:

Mrs M G Baker MBE (Representing patients' interests)

Mrs A M Cherry (Nurse Prescriber)

Professor F D R Hobbs (University Academic/General Practitioner)

Professor P Hutton (Hospital Consultant)

Mr A Reid (Lay)

Mrs L J Stone OBE (Pharmacist)

Professor S R Chapman (Independent body involved in providing information on medicines)

Industry:

Dr S Bews (Recently retired – previously Medical Director, Astellas Pharma Ltd)

Mr T Cousens (Commercial Strategy Director, Internal Medicines, Pfizer UK)

Dr S Dollow (Chief Executive and Founder, Vermillion Life Sciences)

Ms C Horwood (Strategic Medical Projects Officer, Sanofi UK)

Mr D Hope (Head of UK & ROI, Alliance Pharmaceutical Limited)

Dr J Hussein (Dermatology and Respiratory Franchise Head of UK and Ireland, Sanofi Genzyme)

Dr S Kolli (Medical Director, Leo Pharma UK)

Dr M Moodley (Medical Director, Sanofi Genzyme UK and Ireland)

Dr B Phillips (Medical Director, Pfizer UK Limited)

Ms N Pirmohamed, Director, Compliance Officer for UK Ireland and Canada, Biogen Idec Ltd.

Dr P Schofield (Medical Director, Napp Pharmaceuticals Limited)

Mr S Rose (Managing Director, Merz Pharma, UK Ltd)

Dr R Rowsell (Recently retired - Previously Promotional Affairs & Medical Excellence Director, AstraZeneca PLC)

Mr John Russell, (VP Commercial, OUS, Immunocore Limited)